Explore our insights

A deep dive into the SEBI June 2025 ESG guidelines and their impact on India's ESG bond market

The report captures sector-wise shifts, investor alignment with scalable and tech-integrated models, and emerging preferences in early-stage innovation.

The first quarter of 2025 reflected sustained investor attention in India’s healthcare and pharmaceutical sector, marked by consistent deal activity and strategic alignment with long-term growth drivers.

Unlike many other diseases, cancer care is uniquely complex, involving prolonged treatment regimens, high costs, and significant emotional distress for patients and their families.

Get insights on Q3 2024 pharma and healthcare deals covers record-high domestic deals, PE trends, and capital market activity reshaping India's healthcare industry.

Discover Grant Thornton Bharat's insights into the inclusive budget's role in fostering a healthier and vibrant India. Learn about key policies on society.

As India anticipates its new budget announcement, there is a heightened sense of expectation, especially within the Government & Public Services (G&PS) sector.

Q2 2024 sees a advancement in Indian healthcare & pharma deals. Seen increased investments in API, biotechnology, and CDMO segments. Explore insights now.

Our latest report, “Impact of climate change on human health: Decoding the risks,” highlights the urgent need for intersectoral collaboration across environment, health, energy, transport, and food sectors.